{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:29:11Z","timestamp":1792657751005,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.thromres.2009.06.006","type":"journal-article","created":{"date-parts":[[2009,8,6]],"date-time":"2009-08-06T05:35:26Z","timestamp":1249536926000},"page":"297-302","source":"Crossref","is-referenced-by-count":48,"title":["An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran\u00ae)"],"prefix":"10.1016","volume":"125","author":[{"given":"H.N.","family":"Magnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2009.06.006_bib1","first-page":"58","article-title":"Orgaran (Org10172): Its pharmacological profile in experimental models","volume":"22","author":"Meuleman","year":"1992","journal-title":"Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib2","first-page":"66","article-title":"Anticoagulant mechanisms od Orgaran (Org 10172) and its fraction the high affinity to antithrombin III (Org 10849)","volume":"22","author":"Ofosu","year":"1992","journal-title":"Haemost"},{"issue":"6","key":"10.1016\/j.thromres.2009.06.006_bib3","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1182\/blood.V73.6.1592.1592","article-title":"Heparin-induced thrombocytopenia: in-vitro studies with a new low molecular weight heparinoid, Org 10172","volume":"73","author":"Chong","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2009.06.006_bib4","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1111\/j.1538-7836.2008.03171.x","article-title":"Heparin-induced thrombocytopenia \u2013 therapeutic concentrations of danaparoid unlike fondaparinux and direct thrombin inhibitors, inhibit formation of PF4\/heparin complexes","volume":"6","author":"Krauel","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.thromres.2009.06.006_bib5","first-page":"205","article-title":"Pharmacological and clinical strudies with Lomoparan, a low molecular weight glycosaminoglycan","volume":"17","author":"Nurmohamed","year":"1991","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.thromres.2009.06.006_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1160\/TH05-07-0489","article-title":"Heparin induced thrombocytopenia: A report of 1478 clinical outcomes of patients treated with danaparoid (Orgaran\u00ae) from 1982 to mid 2004","volume":"95","author":"Magnani","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2005","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.thromres.2009.06.006_bib8","first-page":"63","article-title":"Treatment of 51 pregnancies with danaparoid because of heparin intolerance","volume":"91","author":"Lindhoff-Last","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib9","series-title":"Heparin-Induced thrombocytopenia","first-page":"319","article-title":"Danaparoid for the treatment of heparin-induced thrombocytopenia","author":"Chong","year":"2007"},{"key":"10.1016\/j.thromres.2009.06.006_bib10","series-title":"Effect of danaparoid on Antiphospholipid Positive Infertile Patients","author":"Adachi","year":"2006"},{"issue":"3","key":"10.1016\/j.thromres.2009.06.006_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-2005-872429","article-title":"Failure of thromboprophylaxis in pregnancy caused by dual deficiencies of Protein S and Protein C","volume":"31","author":"Morikawa","year":"2005","journal-title":"Semin Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib12","series-title":"A case of Pregnancy with Myelodysplastic Syndrome in which Thrombectomy was performed for Pulmonary Thromboembolism during pregnancy","author":"Yamamoto","year":"2007"},{"issue":"3","key":"10.1016\/j.thromres.2009.06.006_bib13","first-page":"347","article-title":"A case of DVT developed in early gestation","volume":"42","author":"Tsutida","year":"2005","journal-title":"Proc Kanto Assoc Japanese Soc Obstet Gynecol"},{"issue":"suppl 1","key":"10.1016\/j.thromres.2009.06.006_bib14","first-page":"102b","article-title":"Successful therapy of heparin-induced thrombocytopenia with thrombosis (HITTS) in pregnancy with danaparoid sodium","volume":"94","author":"Boshkov","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2009.06.006_bib15","first-page":"1","article-title":"Successful use of danaparoid in two pregnant women with heart valve prosthesis and heparin-induced thrombocytopenia Type II (HIT)","author":"Gerhard","year":"2008","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"10.1016\/j.thromres.2009.06.006_bib16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0029-7844(97)00365-7","article-title":"Successful use of danaparoid in treatment of heparin-induced thrombocytopenia during twin pregnancy","volume":"90","author":"Gill","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.thromres.2009.06.006_bib17","article-title":"Heparin induced thrombocytopenia caused by danaparoid sodium","author":"Grainger","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib18","article-title":"Efficacy and safety of danaparoid (Orgaran\u00ae) in venous thrombosis in pregnant women with thrombophilia and heparin-induced thrombocytopemia","author":"Horellou","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib19","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/0003-4975(95)01172-2","article-title":"Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172","volume":"61","author":"Wilhelm","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thromres.2009.06.006_bib20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1055\/s-2002-33711","article-title":"Thromboprophylaxe in der Schwangerschaft nach Polytraumatisiering mit Splenektomie und Immobilisation bei heparininduzierter \u201crelativer\u201d Thrombozytopenie Typ II","volume":"62","author":"Porzelt","year":"2002","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"8","key":"10.1016\/j.thromres.2009.06.006_bib21","first-page":"A18","article-title":"Prophylactic danaparoid in heparin-induced thrombocytopenia presenting with skin manifestations in pregnancy","volume":"13","author":"Gould","year":"2002","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2009.06.006_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00390-006-0639-8","article-title":"Die akute heparineninduzierten Thrombozytopenie Typ II w\u00e4hrend der Schwangerschaft","volume":"43","author":"Schinzel","year":"2006","journal-title":"Intensivmedizin"},{"key":"10.1016\/j.thromres.2009.06.006_bib23","unstructured":"Ducloy-Bouthors A-S, Trillot N, Depret T, Provost-Helou NEnnezat P-V et al. Conduite a tenir diagnostique devant une thrombopenie chez une patiente sous heparine pendent la grossesse, l'accouchement ou le post partum: a propos de 4 cas. 2006 pre-print"},{"key":"10.1016\/j.thromres.2009.06.006_bib24","first-page":"A39","article-title":"Prolonged thrombosis prophylaxis in a pregnant woman with antiphospholipid syndrome and suspected heparin-induced thrombocytopenia: successful use of danaparoid (Orgaran\u00ae)","volume":"24","author":"Lentz","year":"2004","journal-title":"Haemostaseologie"},{"key":"10.1016\/j.thromres.2009.06.006_bib25","unstructured":"Bergmann F. Budde U. Personal communication in ref 35."},{"key":"10.1016\/j.thromres.2009.06.006_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/JPM.2006.100","article-title":"Delivery of a healthy child 30\u00a0weeks after resuscitation for thromboembolism and treatment with danaparoid: 5\u00a0year follow-up","volume":"34","author":"Weilbach","year":"2006","journal-title":"J Perinat Med"},{"key":"10.1016\/j.thromres.2009.06.006_bib27","unstructured":"Olah Z, Schlammadinger A, Laszlo P, Razso K, Boda Z. LMWH treatment and anti-FXa monitoring of complications in pregnant women with thrombophilia. Meeting abstract obtained from The British Library."},{"key":"10.1016\/j.thromres.2009.06.006_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0038-1642546","article-title":"Thrombosis prophylaxis in an AT III deficient pregnant woman: application of a low molecular weight heparinoid","volume":"55","author":"Henny","year":"1986","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0049-3848(91)90665-J","article-title":"Pregnancy associated with lupus anticoagulant and heparin-induced thrombocytopenia: management with a low molecular weight heparinoid","volume":"62","author":"van Besien","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2009.06.006_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0049-3848(93)90178-Q","article-title":"Pregnancy complicated by heparin-associated thrombocytopenia: management by a prospectively in-vitro selected heparinoid (Org 10172)","volume":"71","author":"Greinacher","year":"1993","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.thromres.2009.06.006_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/107602960000600401","article-title":"Thromboembolic prophylaxis with danaparoid (Orgaran\u00ae) in a high thrombosis risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease","volume":"6","author":"Macchi","year":"2000","journal-title":"Clin Appl Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib32","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1471-0528.2002.00052.x","article-title":"Danaparoid prophylaxis in pregnant women with heparin-induced thrombocytopenia","volume":"109","author":"Woo","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.thromres.2009.06.006_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-2002-35284","article-title":"Heparin-induced Thrombocytopenia \u2013 Alternative anticoagulation in pregnancy and lactation","volume":"28","author":"Lindhoff-Last","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib34","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1160\/TH07-10-0610","article-title":"Alternative anticoagulation with danaparoid in two pregnancies in a patient with former heparin-induced thrombocytopenia (HIT), homozygous factor V Leiden mutation, a history of venous thrombosis and recurrent pregnancy losses","volume":"99","author":"Schindewolf","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001721-200103000-00011","article-title":"Management of heparin allergy during pregnancy with danaparoid","volume":"12","author":"Harrison","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"A68","key":"10.1016\/j.thromres.2009.06.006_bib36","article-title":"HELLP syndrome, catastrophic antiphospholipid syndrome or heparin-induced thrombocytopenia?","volume":"15","author":"Rondeau","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.thromres.2009.06.006_bib37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0750-7658(00)00309-9","article-title":"Traitement par le danaparoide de sodium au cours de la grossesse chez une patiente presentant une allergie cutanee aux heparines de bas poids moleculaire","volume":"19","author":"de Saint-Blanquat","year":"2000","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.thromres.2009.06.006_bib38","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0306-5456(01)00215-7","article-title":"Successful use of Heparinoids in a Pregnancy complicated by Allergy to Heparin","volume":"108","author":"Taylor","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.thromres.2009.06.006_bib39","first-page":"131","article-title":"R\u00e9action cutan\u00e9e a l'h\u00e9parine pendant la grossesse: \u00e0 propos d'un cas trait\u00e9 avec succ\u00e8s par le danaparo\u00efde","volume":"43","author":"Deschamps","year":"2003","journal-title":"Rev Fr Allergol Immunol Clin"},{"key":"10.1016\/j.thromres.2009.06.006_bib40","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1600-0412.2003.00337.x","article-title":"Paroxysmal haemoglobinuria in pregnancy","volume":"82","author":"Bj\u00f8rge","year":"2003","journal-title":"Acta Obstet Gynaecol Scand"},{"key":"10.1016\/j.thromres.2009.06.006_bib41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00001721-200312000-00013","article-title":"Eczematous plaques related to unfractionated and low molecular weight heparin in pregnancy: cross reaction with danaparoid sodium","volume":"14","author":"Blickstein","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2009.06.006_bib42","article-title":"Favourable pregnancy outcome in women with a history of venous thromboembolism and prophylactic low molecular weight heparin (LMWH)","volume":"3","author":"Alguel","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib43","doi-asserted-by":"crossref","DOI":"10.1046\/j.1538-7836.2003.t01-7-00115.x","article-title":"High rate of skin complications due to low molecular weight heparins in pregnant women","author":"Bank","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib44","first-page":"45","volume":"vol. 55\/6","author":"Barret","year":"2008"},{"issue":"5","key":"10.1016\/j.thromres.2009.06.006_bib45","first-page":"1569","article-title":"Fondaparinux is a safe alternative in a case of heparin intolerance during pregnancy","volume":"108","author":"Mazzolai","year":"2006","journal-title":"Haemost Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2009.06.006_bib46","series-title":"Heparin-induced Thrombocytopenia","first-page":"21","article-title":"Clinical picture of heparin-induced thrombocytopenia","volume":"2","author":"Warkentin","year":"2007"},{"key":"10.1016\/j.thromres.2009.06.006_bib47","first-page":"73","article-title":"Pharmacokinetics considerations on Orgaran (Org 10172) therapy","volume":"22","author":"Danhof","year":"1992","journal-title":"Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low molecular weight heparins for thromboprophylaxis and treatment of venous thrombolism in prenancy: a systemic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2009.06.006_bib49","unstructured":"Royal College of Obstetricians and Gynaecologists. The Investigation and Treatment of Couple with Recurrent Miscarriage. May 2003, Guideline No 17."},{"key":"10.1016\/j.thromres.2009.06.006_bib50","article-title":"Low molecular weight heparin versus intravenous immunoglobulin for recurrent abortion associated with the antiphospholipid antibody syndrome","author":"Dendrinos","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"10.1016\/j.thromres.2009.06.006_bib51","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/s-0029-1145261","article-title":"Pregnancy outcomes in women with antiphospholipid syndrome: report on a retrospective study","volume":"34","author":"Heilmann","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of pre-term birth","volume":"371","author":"Goldberg","year":"2008","journal-title":"Lancet"},{"issue":"7491","key":"10.1016\/j.thromres.2009.06.006_bib53","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bmj.330.7491.549","article-title":"Pre-eclampsia matters","volume":"330","author":"Greer","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2009.06.006_bib54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mob.2001.114690","article-title":"Heparin-induced thrombocytopenia is rare in pregnancy","volume":"185","author":"Fausett","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"4 Suppl 5","key":"10.1016\/j.thromres.2009.06.006_bib55","first-page":"17","article-title":"Limitations of conventional treatment options for heparin-induced thrombocytopenia","volume":"35","author":"Warkentin","year":"1998","journal-title":"Semin Hematol"},{"key":"10.1016\/j.thromres.2009.06.006_bib56","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1055\/s-0037-1616046","article-title":"Prospective open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopenia with thrombosis","volume":"86","author":"Chong","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib57","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0037-1615946","article-title":"A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia","volume":"85","author":"Farner","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib58","first-page":"507","article-title":"Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod and\/or coumarin explain the rapid shift in clinical practice during the 1990s","volume":"117","author":"Lubenow","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2009.06.006_bib59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1524-4725.2001.00159.x","article-title":"Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid","volume":"27","author":"Grassegger","year":"2001","journal-title":"Am Soc Dermatol Surg"},{"key":"10.1016\/j.thromres.2009.06.006_bib60","first-page":"514","article-title":"The influence of heparin's molelular weight and the incidence of delayed type hypersensitivity reactions revisited","author":"Ludwig","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.thromres.2009.06.006_bib61","first-page":"25","article-title":"R\u00e9action cutan\u00e9e d'hypersensibilit\u00e9 retard\u00e9e avec polisensibilisation aux h\u00e9parines et h\u00e9parinoides","volume":"128","author":"Figarella","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.thromres.2009.06.006_bib62","first-page":"95","article-title":"Toleranz gegen\u00fcber Intraven\u00f6ser Applikation von Heparin und Heparinoid bei einer Patientin mit Typ-IV Allergie auf Heparine und Heparinoide","volume":"19","author":"Boehncke","year":"1996","journal-title":"Allergologie"},{"key":"10.1016\/j.thromres.2009.06.006_bib63","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2141.2004.05321.x","article-title":"Tolerance to intravenous heparin in patients with delayerd type hypersensitivity to heparins: a prospective study","volume":"128","author":"Gaigl","year":"2004","journal-title":"BJH"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384809002722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384809002722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T03:26:16Z","timestamp":1590031576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384809002722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0049384809002722"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2009.06.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}